PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
24304514-7	2014	Thus, the addition of resveratrol to rapamycin treatment may be a promising option for selective and targeted therapy for diseases with TSC loss and mTORC1 hyperactivation.	Resveratrol	22-33	TSC complex subunit 1	Homo sapiens	136-139	
27225870-6	2017	In addition, combination treatment with rapamycin and resveratrol induced cell death specifically in TSC1-/- MEF cells, and not in wild-type MEFs.	Resveratrol	54-65	TSC complex subunit 1	Homo sapiens	101-105